2012
DOI: 10.7314/apjcp.2012.13.8.3695
|View full text |Cite
|
Sign up to set email alerts
|

Mammalian Mediator 19 Mediates H1299 Lung Adenocarcinoma Cell Clone Conformation, Growth, and Metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
1
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 21 publications
0
1
0
Order By: Relevance
“…In line with our and our colleagues' previous discoveries, LCMR1 is positively associated with the proliferative ability of human NSCLC cells [10][11][12][13]. Here, we showed that…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…In line with our and our colleagues' previous discoveries, LCMR1 is positively associated with the proliferative ability of human NSCLC cells [10][11][12][13]. Here, we showed that…”
Section: Discussionsupporting
confidence: 93%
“…In line with our and our colleagues' previous discoveries, LCMR1 is positively associated with the proliferative ability of human NSCLC cells [10][11][12][13]. Here, we showed that LCMR1 can suppress the in vitro and in vivo proliferation of 95D cells-a subcloned cell line derived from a poorly differentiated human LCLC.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…In breast cancer, Med19 may promote cell proliferation by regulating CBFA2T3/HEB expression [ 13 ]. In lung cancer, MED19 could promote tumor proliferation, tumorigenesis, metastasis, and enhance chemo-sensitivity to cisplatin in non-small cell lung cancer cells [ 14 16 ]. The Med19 has been reported to promote tumor growth and/or metastasis in ovarian cancer, gastric cancer, pancreatic cancer, osteosarcoma, and liver cancer [ 5 7 , 17 18 ].…”
Section: Discussionmentioning
confidence: 99%